Literature DB >> 6252222

An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D.

Y Tsuchiya, N Matsuo, H Cho, M Kumagai, A Yasaka, T Suda, H Orimo, M Shiraki.   

Abstract

A 12-yr-old female patient with an unusual form of vitamin D dependency and alopecia is described. She was a product of consanguineous mating and developed signs and symptoms suggesting vitamin D dependency early in life. Neither 150 microgram/day (6 microgram/kg.day) 1 alpha-hydroxyvitamin D3 nor 5 microgram/day (0.2 microgram/kg.day) 1,25-dihydroxyvitamin D3 proved to have an effect on her abnormal serum chemistry. Seven million international units per day (about 2 x 10(5) IU/kg.day) of native vitamin D restored her serum chemistry to normal and brought about marked improvement on skeletal radiographs, when her serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and 24,25-di-hydroxyvitamin D were 4250, 4.8, and 35 ng/ml, respectively. Even with the high serum levels of vitamin D metabolites, her intestinal 47Ca absorption rate remained in the lower normal range and urinary calcium excretion was decidedly low. Association of hypoparathyroidism was ruled out. These results suggest that the patient has extreme and-organ (intestine) hyposensitivity, probably of congenital origin, to the biologically active metabolites of vitamin D.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252222     DOI: 10.1210/jcem-51-4-685

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia.

Authors:  L J Fraher; R Karmali; F R Hinde; G N Hendy; H Jani; L Nicholson; D Grant; J L O'Riordan
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

2.  The mechanism of end-organ resistance to 1 alpha,25-dihydroxycholecalciferol in the common marmoset.

Authors:  N Takahashi; S Suda; T Shinki; N Horiuchi; Y Shiina; Y Tanioka; H Koizumi; T Suda
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

3.  Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.

Authors:  S Balsan; M Garabédian; M Larchet; A M Gorski; G Cournot; C Tau; A Bourdeau; C Silve; C Ricour
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Rickets with alopecia-remission following a course of 1-alpha-hydroxy vitamin D3 therapy.

Authors:  D S Manandhar; S Sarkawi; M C Hunt
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

5.  Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts.

Authors:  U A Liberman; C Eil; S J Marx
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

6.  Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.

Authors:  G T Gamblin; U A Liberman; C Eil; R W Downs; D A DeGrange; S J Marx
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

7.  Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.

Authors:  J E Griffin; J E Zerwekh
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

8.  Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981.

Authors:  S W Stanbury
Journal:  J R Coll Physicians Lond       Date:  1981-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.